Nomura Securities Maintains a 'Buy' on Capital One Financial (COF); Raising PT
Get Alerts COF Hot Sheet
Price: $215.55 -2.35%
Rating Summary:
28 Buy, 14 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 12 | New: 19
Rating Summary:
28 Buy, 14 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 12 | New: 19
Join SI Premium – FREE
Nomura Securities maintains a 'Buy' on Capital One Financial (NYSE: COF) price target raised from $54 to $60.
Analyst, Brian Foran, said, "While 2012 numbers will remain very noisy, we continue to see $6.50 of EPS in 2013 on a GAAP basis and over $7 on a cash basis. As a result, we maintain our rating and roll forward our price target to 2013, resulting in a $60 target using a 9x multiple. Lastly, we do a deep dive on loan growth seasonality and find that store card has 2-3x the seasonality of regular card business, implying every year COF will have best-in-class month-on-month loan growth in 4Q and worst-in-class loan growth in 1Q."
For an analyst ratings summary and ratings history on Capital One Financial click here. For more ratings news on Capital One Financial click here.
Shares of Capital One Financial closed at $54.08 yesterday.
Analyst, Brian Foran, said, "While 2012 numbers will remain very noisy, we continue to see $6.50 of EPS in 2013 on a GAAP basis and over $7 on a cash basis. As a result, we maintain our rating and roll forward our price target to 2013, resulting in a $60 target using a 9x multiple. Lastly, we do a deep dive on loan growth seasonality and find that store card has 2-3x the seasonality of regular card business, implying every year COF will have best-in-class month-on-month loan growth in 4Q and worst-in-class loan growth in 1Q."
For an analyst ratings summary and ratings history on Capital One Financial click here. For more ratings news on Capital One Financial click here.
Shares of Capital One Financial closed at $54.08 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- Marti Technologies (MRT) PT Raised to $6 at Benchmark on Stronger Growth, Improved Earnings Visibility
- Okta, Inc (OKTA) PT Raised to $170 at Cantor Fitzgerald Ahead of Q2 Results
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS View, Analyst PT ChangeRelated Entities
NomuraSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share